Defense. Intelligence. Integrity.
Legal strategy for business-critical criminal risk.
CLRI Group helps companies prevent, investigate, manage and defend complex criminal risks that may threaten reputation, executives, operations, brands, assets and business continuity.
Request a Strategic Consultation
We work at the intersection of corporate criminal law, compliance, internal investigations, crisis management and business strategy. Our role is to anticipate criminal exposure, understand it with investigative rigor and respond with precision, discretion and integrity.
CLRI Pharma is a specialized practice area of the Firm focused on criminal enforcement, anti-counterfeiting strategies, brand protection through criminal law, and legal support in investigations related to these matters for pharmaceutical and life sciences companies.
We help pharmaceutical companies address the criminal threat posed by counterfeit medicines, falsified pharmaceutical products, illicit distribution networks, unauthorized sales, and trademark counterfeiting. Our team works with internal investigation teams, brand protection units, external investigators, legal departments, compliance teams, and authorities to transform investigative findings into solid criminal actions.
Founder & Managing Partner.
Joaquín Chávez A. is a Mexican corporate criminal lawyer with more than 18 years of experience advising national and multinational companies in high-impact criminal matters. He has focused his practice on corporate criminal law, compliance, criminal risk prevention, internal investigations, security governance, crisis management, intellectual property crimes, and the protection of companies facing complex criminal exposure. He previously served as Security Governance & Crime Prevention Manager LATAM, strengthening his ability to connect legal strategy with corporate decision-making, governance, investigations, and operational risk management. He has extensive experience advising multinational pharmaceutical companies on the design, implementation, and execution of anti-counterfeiting strategies focused on combating counterfeit medicines. In 2024, he secured a conviction in a criminal case involving the sale of counterfeit medicines.
Let’s discuss your matter with discretion.
For sensitive corporate criminal risk matters, anti-counterfeiting enforcement, investigations, compliance or crisis response, contact CLRI Group.